Aldosterone induces contraction of the resistance arteries in man

Atherosclerosis

Volumn 166, Issue 2, 2003, Pages 345-349

  Romagni, Paola ^a   Rossi, Fabio ^a   Guerrini, Lara ^a   Quirini, Chiara ^a   Santiemma, Vittorio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Aldosterone; Forearm blood flow; Nongenomic; Plethysmography; Vascular resistance

Indexed keywords

ALDOSTERONE; PLACEBO;

ADULT; ARTERY CONSTRICTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOCUMENTATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FOREARM BLOOD FLOW; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; VEIN OCCLUSION PLETHYSMOGRAPHY;

ADULT; ALDOSTERONE; BLOOD PRESSURE DETERMINATION; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FOREARM; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PLETHYSMOGRAPHY; PROBABILITY; REFERENCE VALUES; REGIONAL BLOOD FLOW; SENSITIVITY AND SPECIFICITY; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0037300633     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00363-5     Document Type: Article

References (30)

1. Wehling M. Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59:1997;365-393.
2. Christ M., Wehling M. Rapid actions of aldosterone: Lymphocytes, vascular smooth muscle and endothelial cells. Steroids. 64:1999;35-41.
3. Wehling M., Ulsenheimer A., Schneider M., Neylon C., Christ M. Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: Subcellular localization of calcium elevations by single cell imaging. Biochem. Biophys. Res. Comm. 204:1994;475-481.
4. Funder J.W. Non-genomic actions of aldosterone: Role in hypertension. Curr. Opin. Nephrol. Hypertens. 10:2001;227-230.
5. Zange J., Muller K., Gerzer R., Sippel K., Wehling M. Nongenomic effects of aldosterone on phosphocreatine levels in human calf muscle during recovery from exercise. J. Clin. Endocrinol. Metab. 81:1996;4296-4300.
6. Wehling M., Christoph H.S. Rapid cardiovascular action of aldosterone in man. J. Clin. Endocrinol. Metab. 83:1998;3517-3522.
7. Schmidt B., Montealegre A., Martin J., et al. Short term cardiovascular effects of aldosterone in healthy male volunteers. J. Clin. Endocrinol. Metab. 84:1999;3528-3533.
8. Schmidt B., Georgens C., Martin N., Tillmann H., Feuring M., Christ M., Wehling M. Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system. J. Clin. Endocrinol. Metab. 86:2001;761-767.
9. Bejamin N., Calver A., Collier J., Robinson B., Vallance P., Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 25:1995;918-923.
10. Haynes W.G., Clarke J.G., Cockcroft J.R., Webb D.J. Pharmacology of endothelin-1 in vivo in humans. J. Cardiovasc. Pharmacol. 17:(7):1991;S284-286.
11. Ritter J.M., Cockcroft J.R., Sciberras D.G., Goldberg M.R. Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature. J. Hypertens. 11:1993;S59-61.
12. Benjamin N., Calver A., Collier J., Robinson B. Measuring forearm blood flow and interpreting the response to drugs and mediators. Hypertension. 25:1995;918-923.
13. Panza J.A., Quyyumi A.A., Brush J.E., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. New Engl. J. Med. 323:1996;22-27.
14. Angus J.A. Role of endothelium in the genesis of cardiovascular disease. Clin. Exp. Pharmacol. Physiol. 23:1996;S16-22.
15. Baan J. Jr, Chang P.C., Vermeij P., Pfaffendorf M., van Zwieten P.A. Effects of angiotensin II and losartan in the forearm of patients with essential hypertension. J. Hypertens. 16:1998;1299-1305.
16. Taddei S., Virdis A., Ghiadoni L., Mattei P., Salvetti A. Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients. J. Hypertens. 16:1998;447-456.
17. Goldsmith S.R., Garr M., McLaurin M. Regulation of regional norepinephrine spillover in heart failure: The effect of angiotensin II and beta-adrenergic agonists in the forearm circulation. J. Card. Fail. 4:1998;305-310.
18. Hogikyan R.V., Galecki A.T., Pitt B., Halter J.B., Greene D.A., Supiano M.A. Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity. J. Clin. Endocrinol. Metab. 83:1998;1946-1952.
19. McAuley D.F., McGurk C., Nugent A., Hanratty C., Hayes J.R., Johnston G.D. Vasoconstriction to endothelin-1 is blunted in non-insulin-dependent diabetes: A dose-response study. J. Cardiovasc. Pharmacol. 36:2000;203-208.
20. Weber M.A., Purdy R.E. Catecholamine-mediated constrictor effects of aldosterone on vascular smooth muscle cells. Life Sci. 30:1982;2009-2017.
21. Taddei S., Virdis A., Mattei P., Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 21:1993;929-933.
22. Schiffrin E.L., Franks D.J., Gutkwoska J. Effect of aldosterone on vascular angiotensin II receptors in the rat. Can. J. Physiol. Pharmacol. 63:1985;1522-1527.
23. Ullian M.E., Fine J.J. Mechanics of enhanced angiotensin II-stimulated signal transduction in vascular smooth muscle by aldosterone. J. Cell Physiol. 16:1994;201-208.
24. Ebata S., Muto S., Okada K., Nemoto J. Aldosterone activates Na/H exchanges in vascular smooth muscle cells by nongenomic and genomic mechanisms. Kidney Int. 56:1999;1400-1412.
25. Xiao F., Puddefoot J.R., Vinson G.P. Aldosterone mediates angiotensin II-stimulated rat vascular smooth muscle cells proliferation. J. Endocrinol. 165:2000;533-536.
26. Takeda Y., Miyamori I., Yoneda T., et al. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin-II and adrenocorticotropin. J. Clin. Endocrinol. Metab. 81:1996;2797-2800.
27. Hatakeyama H., Miyamori I., Takeda Y., Yamamoto H. The expression of steroidogenic enzyme genes in human vascular cells. Biochem. Mol. Biol. Int. 40:1996;639-645.
28. Hatakeyama H., Miyamori I., Fijita T., Takeda Y., Takeda R., Yamamoto H. Vascular aldosterone. Biosynthesis and link to angiotensin-II-induced hypertrophy of vascular smooth muscle cells. J. Biol. Chem. 269:1994;24316-24320.
29. Kornel L. Colocalization of 11-beta-hydroxysteroid dehydrogenase and mineral corticoid receptors in cultured vascular smooth muscle cells. Am. J. Hypertens. 7:1994;100-103.
30. Rocha R., Stier C.T. Jr. Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol. Metab. 12:2001;308-314.